Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$320.5M
-19.5% from 2023
Prescriptions
715K
$448.05 per claim
Patients
200K
112,840 prescribers
Total spending, 2024
$320.6M
$1,602.29 per patient
Medicare prescription drug plans paid $320.5M for Advair Hfa in 2024, for 715,285 prescriptions and refills to 200,004 patients (down 19.5% from 2023). The average cost per claim was $448.05.
California had the highest Medicare cost for Advair Hfa in 2024: $28.8M for 65,454 claims, followed by New York ($20.5M).
Kelly L Dudley, nurse practitioner in Augusta, ME, had the highest Medicare cost for Advair Hfa in 2024: 404 claims costing $270K.
Advair Hfa is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kelly L Dudley Augusta, ME | Nurse Practitioner | 404 | 119 | $270K |
| Huan A Le San Diego, CA | Pulmonary Disease | 638 | 199 | $260K |
| Asker Asmi Riverview, MI |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 99,651 | 631,891 | 172,945 | $384.6M |
| 2023 | 103,105 | 651,148 | 180,274 | $398.2M |
| 2024 | 112,840 | 715,285 | 200,004 | $320.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 373 |
| 111 |
| $183K |
| Paulette Ong Davenport, IA | Physician Assistant | 391 | 69 | $172K |
| Kristine R Kuhl Houston, TX | Pulmonary Disease | 334 | 106 | $153K |
| Jessica L Bagley Battle Creek, MI | Nurse Practitioner | 291 | 65 | $147K |
| Jonathan J Danaraj Spokane, WA | Pulmonary Disease | 292 | 74 | $145K |
| Mirna B Ayache Cleveland, OH | Pulmonary Disease | 219 | 61 | $134K |
| Amit Dhingra Peoria, AZ | Pulmonary Disease | 347 | 77 | $132K |
| Nataliya Sevastyanova Springfield, MA | Nurse Practitioner | 274 | 66 | $129K |
| Wendy A Neveu Atlanta, GA | Pulmonary Disease | 173 | 52 | $127K |
| Hataya K Poonyagariyagorn Beaverton, OR | Pulmonary Disease | 193 | 51 | $126K |
| Francis Lam Sacramento, CA | Internal Medicine | 145 | 49 | $126K |
| Jahaira L Serrano Dominguez Arecibo, PR | Pulmonary Disease | 279 | 88 | $120K |
| Susan S Cho Corvallis, OR | Pulmonary Disease | 182 | 50 | $119K |
| Lawrence G Kramer Watertown, NY | Pulmonary Disease | 152 | 43 | $116K |
| Emanuel I Wurm Somers, NY | Pulmonary Disease | 225 | 49 | $116K |
| Usha Chandrahasa Port Charlotte, FL | Allergy/ Immunology | 244 | 59 | $112K |
| Mark J Biagtan Madison, WI | Allergy/ Immunology | 272 | 53 | $112K |
| Candace H Wortham Lagrange, GA | Nurse Practitioner | 217 | 51 | $111K |
| Elio Donna Miami, FL | Pulmonary Disease | 241 | 52 | $108K |
| Daniel Martin N Dartmouth, MA | Internal Medicine | 240 | 66 | $107K |
| John E Daniels Wauwatosa, WI | Pulmonary Disease | 210 | 60 | $105K |
| Jay E Brown Ames, IA | Allergy/ Immunology | 223 | 67 | $105K |
| Natalia I Moguillansky Gainesville, FL | Critical Care (Intensivists) | 120 | 45 | $105K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 715,505 | $320.6M |